Stockreport

Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026 [Yahoo! Finance]

Calidi Biotherapeutics, Inc.  (CLDI) 
PDF the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will present new data at the American Association of Cancer Research (A [Read more]